Back
Blueprint Medicines Vs. Sage Group (The) PLC Industry Stock Comparison
Sell
37
BPMC
Blueprint Medicines
Last Price:
96.58
Seasonality Move:
-0.18%
Buy
96
SGPYY
Sage Group (The) PLC
Last Price:
64.21
Seasonality Move:
5.99%
Sell
37
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
- The current Blueprint Medicines [BPMC] share price is $94.81. The Score for BPMC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
96
Sage Group (The) PLC (SGPYY)
is a Buy
Is Sage Group (The) PLC a Buy, Sell or Hold?
- The current Sage Group (The) PLC [SGPYY] share price is $64.96. The Score for SGPYY is 96, which is 92% above its historic median score of 50, and infers lower risk than normal.
- SGPYY is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $94.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
SGPYY Stock Price Chart
What is Sage Group (The) PLC's stock price today?
-
The Sage Group (The) PLC share price today is $64.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SGPYY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.39 | Buy |
| Relative Strength Index (14 RSI): | 54.43 | Buy |
| Chaikin Money Flow: | 456578 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (85.11 - 97.25) | Buy |
| Bollinger Bands (100): | (85.77 - 106.49) | Sell |
SGPYY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.31 | Buy |
| Relative Strength Index (14 RSI): | 81.86 | Buy |
| Chaikin Money Flow: | 32695 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.93 - 56.35) | Buy |
| Bollinger Bands (100): | (52.06 - 55.62) | Buy |
BPMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 94.66 | Buy |
| 20-day SMA: | 92.39 | Buy |
| 50-day SMA: | 90.02 | Buy |
| 200-day SMA: | 95.85 | Sell |
| 8-day EMA: | 94.12 | Buy |
| 20-day EMA: | 93.09 | Buy |
| 50-day EMA: | 92.24 | Buy |
| 200-day EMA: | 91.11 | Buy |
SGPYY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.93 | Buy |
| 20-day SMA: | 53.67 | Buy |
| 50-day SMA: | 53.72 | Buy |
| 200-day SMA: | 56.64 | Buy |
| 8-day EMA: | 56.68 | Buy |
| 20-day EMA: | 54.71 | Buy |
| 50-day EMA: | 53.93 | Buy |
| 200-day EMA: | 54.47 | Buy |
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.64 per share.
Sage Group (The) PLC Earnings Growth & SGPYY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Blueprint Medicines Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sage Group (The) PLC Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||